Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
4.4 GBX 0.00(0%)
Last update at 2026-10-27T15:21:00Z
VOLUME
523981
Market Cap
69.06M

Momentum Score

…

Agronomics Limited is a private equity and venture capital firm specializing in emerging growth, seed/startup, early venture, series B and growth capital investments. The firm invests in quoted and unquoted companies. It prefers to invest in the alternative proteins company with a focus on cellular agriculture, cultivated meat, technologies, nascent industry of modern foods and materials, biopharma sector and will establish a portfolio of investments in biotechnology and biopharmaceutical companies. It also seeks to invest in clean food and biomanufacturing. The firm may also invest in shares of collective investment schemes with exposure to the biopharma sector and in long-term equity anticipation securities the underlying securities of which will be based on biopharma sector securities and/or indices relating to the biopharma Sector. It makes minority investments in portfolio companies. It may invest in biopharma sector debt, where investments shall not exceed 15 per cent of the net asset value of the company. The firm prefers to invest from its balance sheet capital. Agronomics Limited was founded on May 3, 2011 and is based in Ramsey, Isle of Man.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
4.30
Low
4.50
High
52 Week Price Range
5.20
Low
9.60
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Agronomics Ltd is a London-listed investment company that backs early-stage and scaling businesses in cellular agriculture, cultivated proteins and precision fermentation. Long-term growth may be driven by rising demand for sustainable proteins, technological progress that lowers production costs and broader commercialization. The company provides public-market exposure to a diversified portfolio in a sustainability-focused subsector.
Principal risks include technology and execution failure common to early-stage food-tech, regulatory and consumer acceptance uncertainty, funding needs for portfolio companies and significant share volatility from illiquid holdings.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
4.40
Dividend Yield
-
Revenue TTM
-12.14M
Revenue Per Share
-0.01
Gross Profit TTM
-12.14M
Debt / Equity
-
ROE
-11.13%
Net Debt
-3.61M
ROCE
-21.26%
Diluted EPS TTM
-0.02

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -32.75M -10.99M 22.37M 8.36M 1.02M
Net income -32.75M -10.99M 22.37M 5.96M -7.70M
Selling general administrative 0.55M 0.15M 3.49M 5.68M 8.08M
Selling and marketing expenses - 0.18M 0.15M 0.14M -
Gross profit - -8.34M 29.70M - -
Ebit - - -10.28M 11.10M 9.74M
Ebitda -26.47M - -34.84M -11.35M -20.36M
Depreciation and amortization - 10.02M -24.57M -22.44M -30.10M
Operating income -26.47M -12.16M 24.57M 11.10M 9.74M
Other operating expenses 14.56M 3.82M 5.13M 4.92M 9.69M
Interest expense - - - 0.34M 0.00M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Interest income 1.47M 1.17M 1.17M 0.34M 0.15M
Net interest income 1.47M 1.17M 1.17M 0.34M 0.15M
Income tax expense - - 24.56M 2.40M 8.72M
Total revenue -11.92M -8.34M 29.70M 0.00M 0.00M
Total operating expenses 14.56M 3.82M 5.13M 4.92M 9.69M
Total other income expense net -6.28M 1.18M -2.20M -2.74M -8.72M
Net income from continuing ops -32.75M -10.99M 22.37M 8.36M 1.02M
Net income applicable to common shares - - - 8.36M 1.02M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 124.67M 157.44M 170.20M 146.40M 101.65M
Other current assets -124.67M 8.71M 141.77M 0.10M 0.45M
Total liab 0.15M 0.17M 1.95M 2.49M 1.62M
Total stockholder equity 124.52M 157.27M 168.26M 143.91M 100.03M
Other current liab 0.15M 0.06M 1.74M 2.34M 1.52M
Common stock 0.00M 0.00M 0.00M 0.00M 0.00M
Capital stock 0.00M 0.00M 0.00M 0.00M 0.00M
Retained earnings -11.65M 21.10M 32.09M 9.71M 1.36M
Other assets 124.67M 157.44M -132.66M - -
Cash 3.61M 3.13M 18.09M 31.46M 62.44M
Total current liabilities 0.15M 0.17M 1.95M 2.49M 1.62M
Net debt -3.61M -3.13M -18.09M -31.46M -62.44M
Other stockholder equity 136.17M 136.17M 134.48M 134.20M 98.67M
Total current assets 19.07M 20.95M 170.20M 146.40M 101.65M
Net tangible assets - - - 143.91M 100.03M
Short term investments 121.01M 9.11M 10.00M 114.84M 38.77M
Net receivables 0.05M 8.71M 0.34M 0.10M 0.45M
Inventory - - -141.77M - -
Accounts payable 0.09M 0.11M 0.20M 0.15M 0.10M
Accumulated other comprehensive income - - 1.69M - -
Non currrent assets other - 9.11M 141.77M - -
Non current assets total 105.60M 136.49M 132.66M 0.00M 0.00M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments 9.11M 0.89M 10.02M -20.02M -20.02M
Change to liabilities - - - 0.87M 1.69M
Total cashflows from investing activities 1.59M 0.89M 10.02M -20.02M -20.02M
Net borrowings - - - - 1.90M
Total cash from financing activities 0.00M 0.00M 1.01M 31.25M 71.82M
Net income -32.75M -10.99M 22.37M 8.36M 1.02M
Change in cash -8.63M -14.97M -13.36M -30.98M 59.65M
Begin period cash flow 12.24M 18.09M 31.46M 62.44M 2.79M
End period cash flow 3.61M 3.13M 18.09M 31.46M 62.44M
Total cash from operating activities -1.12M -15.86M -24.40M -42.21M -12.17M
Issuance of capital stock 0.00M 0.00M 0.28M 32.06M 73.37M
Other cashflows from investing activities 9.11M 0.89M 10.02M - -
Change to account receivables 0.00M 0.28M -0.23M 0.32M -0.43M
Other cashflows from financing activities - - 0.73M -0.80M -1.55M
Change to netincome - - - -51.76M -14.45M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital -0.01M -1.50M -0.77M 1.19M 1.26M
Stock based compensation - - 1.69M - -
Other non cash items 31.65M -3.37M -46.00M -51.76M -14.45M
Free cash flow -1.12M -15.86M -23.67M -42.21M -12.17M

Peer Comparison*

Sector: Financial Services Industry: Asset Management

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
ANIC
Agronomics Ltd
-
-%
4.40 - 6.69 3.96 0.50 166.84 5.59
MNTN
Schiehallion Fund Ltd
-0.01
0.46%
2.18 0.05 - 4.35 1.25 5.65 -
BHMU
BH Macro Limited
-
-%
4.29 0.09 - 39.01 0.71 6.47 -
TFG
Tetragon Financial Group Ltd
0.15
1.00%
15.10 0.02 7.04 1.16 0.31 2.06 6.56
BPCR
BioPharma Credit PLC
0.00
0.41%
0.98 0.09 - 6.73 0.91 7.95 -

Profile*

Agronomics Ltd

Agronomics Limited is a private equity and venture capital firm specializing in emerging growth, seed/startup, early venture, series B and growth capital investments. The firm invests in quoted and unquoted companies. It prefers to invest in the alternative proteins company with a focus on cellular agriculture, cultivated meat, technologies, nascent industry of modern foods and materials, biopharma sector and will establish a portfolio of investments in biotechnology and biopharmaceutical companies. It also seeks to invest in clean food and biomanufacturing. The firm may also invest in shares of collective investment schemes with exposure to the biopharma sector and in long-term equity anticipation securities the underlying securities of which will be based on biopharma sector securities and/or indices relating to the biopharma Sector. It makes minority investments in portfolio companies. It may invest in biopharma sector debt, where investments shall not exceed 15 per cent of the net asset value of the company. The firm prefers to invest from its balance sheet capital. Agronomics Limited was founded on May 3, 2011 and is based in Ramsey, Isle of Man.

Viking House, Ramsey, Isle of Man, IM8 1GB

44 1624 811454

Name Title Year Born
Mr. Denham Hervey Newall Eke Fin. Director & Exec. Director 1952
Mr. James Mellon M.A. Exec. Director 1957
Mr. Anthony Chow CFA Co-Founder NA
Mr. James Mellon M.A. Co-Founder & Executive Chairperson 1957
Mr. Denham Hervey Newall Eke Finance Director & Executive Director 1951

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…